Patents Assigned to HEMOCEPT INC.
  • Patent number: 12251239
    Abstract: A system using combined electrocardiography (EKG) and photoplethysmography (PPG) sensing to assess intra-arterial fluid volume is described. The system uses averaging of similar pulses based on prior (n?1; n minus 1) R-to-R pulse wave duration, and prior-prior (n?2; n minus 2) R-to-R pulse wave duration, to determine a patient's fluid status and whether it is below or above optimal intravascular hydration.
    Type: Grant
    Filed: October 30, 2023
    Date of Patent: March 18, 2025
    Assignee: HEMOCEPT INC.
    Inventors: Eric Raman, Kevin Peterson, Iain Hueton
  • Patent number: 12076168
    Abstract: A system using combined electrocardiography (EKG) and photoplethysmography (PPG) sensing, to determine venous oxygen saturation is described. The system uses averaging of similar pulses based on Prior (or n?1) R-to-R pulse wave duration, and current (or n) R-to-R pulse wave duration for evaluation of the metabolic reserve and/or stress of the patient.
    Type: Grant
    Filed: April 13, 2021
    Date of Patent: September 3, 2024
    Assignee: HEMOCEPT INC.
    Inventors: Eric Raman, Kevin Peterson, Iain Hueton
  • Patent number: 11896405
    Abstract: A system using combined electrocardiography (EKG) and photoplethysmography (PPG) sensing, to determine venous oxygen saturation is described. The system uses averaging of similar pulses based on Prior (or n?1) R-to-R pulse wave duration, and current (or n) R-to-R pulse wave duration for evaluation of the metabolic reserve and/or stress of the patient.
    Type: Grant
    Filed: April 13, 2021
    Date of Patent: February 13, 2024
    Assignee: HEMOCEPT INC.
    Inventors: Eric Raman, Kevin Peterson, Iain Hueton
  • Patent number: 11801016
    Abstract: A system using combined electrocardiography (EKG) and photoplethysmography (PPG) sensing to assess intra-arterial fluid volume is described. The system uses averaging of similar pulses based on prior (n?1; n minus 1) R-to-R pulse wave duration, and prior-prior (n?2; n minus 2) R-to-R pulse wave duration, to determine a patient's fluid status and whether it is below or above optimal intravascular hydration.
    Type: Grant
    Filed: April 13, 2021
    Date of Patent: October 31, 2023
    Assignee: HEMOCEPT INC.
    Inventors: Eric Raman, Kevin Peterson, Iain Hueton